MARINUS ANTONIUS JACOBUS
HERMSEN
Ikertzaileren 2004-2018 tartean
Broad Institute
Cambridge, Estados UnidosBroad Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
BAY 2927088: The first non-covalent, potent, and selective tyrosine kinase inhibitor targeting EGFR exon 20 insertions and C797S resistance mutations in NSCLC
European Journal of Cancer, Vol. 174, pp. S9-S10